\-\ Texto\\:\\ \ \(0\)\
\-\ bibasilar\\ crackles\ \(4\)\
\-\ this\\ case\\:\\ treated\\ with\\ corticosteroid\\ therapy\\ with\\ improvement\\ of\\ symptoms\\ and\\ ct\\ findings\\.\ \(0\)\
\-\ in\\ general\\:\\ \\ removal\\ from\\ antigen\\ exposure\\ \\+\\/\\-\\ corticosteroid\\ treatment\\.\ \(0\)\
\-\ cxr\\:\\ bibasilar\\ linear\\ interstitial\\ pattern\ \(0\)\
\-\ ct\\ \\(pe\\ study\\)\\:\\ diffuse\\ ground\\ glass\\ greater\\ at\\ bases\ \(0\)\
\-\ extrinsic\\ allergic\\ alveolitis\\ \\(hypersensitivity\\ pneumonitis\\)\\-acute\ \(0\)\
\-\ 1\\)hypersensitivity\\ pneumonitis\ \(0\)\
\-\ 2\\)acute\\ interstitial\\ disease\\ \\(dip\\,\\ aip\\,\\ viral\\)\ \(0\)\
\-\ 3\\)eosinophilic\\ pneumonia\ \(0\)\
\-\ 4\\)pulmonary\\ edema\ \(0\)\
\-\ 34\\ y\\/o\\ male\\ with\\ cough\\ and\\ dyspnea\\.\\ \\ no\\ specific\\ exposures\\.\ \(0\)\
\-\ chest\\ x\\-ray\\ findings\\:\ \(1\)\
\-\ acute\\:\\ diffuse\\ micronodular\\ interstitial\\ pattern\\.\\ \\ \\(\\+\\/\\-\\ ground\\-glass\\ density\\ in\\ the\\ lower\\ and\\ middle\\ lung\\ zones\\)\\.\\ \\ normal\\ in\\ 10\\%\\.\\ \ \(0\)\
\-\ subacute\\:\\ micronodular\\ or\\ reticular\\ opacities\\ are\\ most\\ prominent\\ in\\ mid\\-to\\-upper\\ lung\\ zones\\.\ \(0\)\
\-\ chronic\\:\\ progressive\\ fibrotic\\ changes\\ with\\ loss\\ of\\ lung\\ volume\\ particularly\\ affect\\ the\\ upper\\ lobes\\.\\ nodular\\ or\\ ground\\-glass\\ opacities\\ are\\ not\\ features\\.\\ \ \(0\)\
\-\ \\	\ \(2191\)\
\-\ hrct\\ findings\\:\ \(0\)\
\-\ acute\\:\\ ground\\-glass\\ or\\ diffusely\\ increased\\ opacities\\.\\ \ \(0\)\
\-\ subacute\\:\\ \\ diffuse\\ micronodules\\,\\ ground\\-glass\\,\\ focal\\ air\\ trapping\\,\\ and\\ mild\\ fibrotic\\ changes\\.\ \(0\)\
\-\ chronic\\:\\ \\ may\\ see\\ mixture\\ of\\ ground\\ glass\\,\\ air\\ trapping\\,\\ cystic\\ changes\\ with\\ fibrotic\\ changes\\.\ \(0\)\
\-\ diagnosis\\:\\ \\ combination\\ of\\ clinical\\,\\ radiographic\\,\\ pft\\'s\\,\\ and\\ bronchioalveolar\\ lavage\\ can\\ suggest\\ diagnosis\\.\\ \\ biopsy\\ may\\ be\\ needed\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ ground\\-glass\\:\\ 0\\.10857721285092067\ \(0\)\
\-\ fibrotic\\:\\ 0\\.08143290963819051\ \(0\)\
\-\ \\:\\:\\ 0\\.0653047671461273\ \(0\)\
\-\ micronodular\\:\\ 0\\.06405404899139909\ \(0\)\
\-\ opacities\\:\\ 0\\.05945079463035876\ \(0\)\
\-\ interstitial\\:\\ 0\\.05574385914315817\ \(0\)\
\-\ \\+\\/\\-\\:\\ 0\\.051731432448111174\ \(0\)\
\-\ zones\\:\\ 0\\.051731432448111174\ \(0\)\
\-\ hypersensitivity\\:\\ 0\\.0504891040714431\ \(0\)\
\-\ pneumonitis\\:\\ 0\\.0504891040714431\ \(0\)\
\-\ trapping\\:\\ 0\\.04939930565284458\ \(0\)\
\-\ bibasilar\\:\\ 0\\.04906383607077484\ \(0\)\
\-\ corticosteroid\\:\\ 0\\.048740568122589284\ \(0\)\
\-\ glass\\:\\ 0\\.04394948811607651\ \(0\)\
\-\ changes\\:\\ 0\\.0435386306886233\ \(0\)\
\-\ ground\\:\\ 0\\.04181906275371722\ \(0\)\
\-\ aip\\:\\ 0\\.039180081884295545\ \(0\)\
\-\ mid\\-to\\-upper\\:\\ 0\\.039180081884295545\ \(0\)\
\-\ pft\\:\\ 0\\.039180081884295545\ \(0\)\
\-\ subacute\\:\\ 0\\.038975125556650524\ \(0\)\
\-\ micronodules\\:\\ 0\\.03609942774847357\ \(0\)\
\-\ diffuse\\:\\ 0\\.034493432271670864\ \(0\)\
\-\ bronchioalveolar\\:\\ 0\\.03429736060132617\ \(0\)\
\-\ lung\\:\\ 0\\.03300212160318328\ \(0\)\
\-\ alveolitis\\:\\ 0\\.03121670646550419\ \(0\)\
\-\ exposures\\:\\ 0\\.03121670646550419\ \(0\)\
\-\ pattern\\:\\ 0\\.029035043013966918\ \(0\)\
\-\ hrct\\:\\ 0\\.028946370359877568\ \(0\)\
\-\ \\-acute\\:\\ 0\\.028522769560747233\ \(0\)\
\-\ acute\\:\\ 0\\.028131724388086605\ \(0\)\
\-\ antigen\\:\\ 0\\.02745093819711662\ \(0\)\
\-\ lavage\\:\\ 0\\.02745093819711662\ \(0\)\
\-\ mixture\\:\\ 0\\.025865716224055587\ \(0\)\
\-\ air\\:\\ 0\\.025700112236017477\ \(0\)\
\-\ \\)\\:\\ 0\\.025370229052917515\ \(0\)\
\-\ dip\\:\\ 0\\.02524455203572155\ \(0\)\
\-\ allergic\\:\\ 0\\.024873967107103545\ \(0\)\
\-\ reticular\\:\\ 0\\.02469965282642229\ \(0\)\
\-\ findings\\:\\ 0\\.02425115914386613\ \(0\)\
\-\ extrinsic\\:\\ 0\\.023378534944342597\ \(0\)\
\-\ crackles\\:\\ 0\\.022068314765584178\ \(0\)\
\-\ affect\\:\\ 0\\.02188310278158165\ \(0\)\
\-\ bases\\:\\ 0\\.021705301294409653\ \(0\)\
\-\ chronic\\:\\ 0\\.021395463403617778\ \(0\)\
\-\ eosinophilic\\:\\ 0\\.02036183075275217\ \(0\)\
\-\ exposure\\:\\ 0\\.019760313651108787\ \(0\)\
\-\ particularly\\:\\ 0\\.019594663007565533\ \(0\)\
\-\ diffusely\\:\\ 0\\.019180927793938814\ \(0\)\
\-\ viral\\:\\ 0\\.019131817410887327\ \(0\)\
\-\ combination\\:\\ 0\\.019131817410887327\ \(0\)\
\-\ 34\\:\\ 0\\.01884803309094718\ \(0\)\
\-\ dyspnea\\:\\ 0\\.017977039108892593\ \(0\)\
\-\ volume\\:\\ 0\\.017939533026022084\ \(0\)\
\-\ improvement\\:\\ 0\\.01772090971850754\ \(0\)\
\-\ diagnosis\\:\\ 0\\.017441949606937065\ \(0\)\
\-\ x\\-ray\\:\\ 0\\.01712299463869596\ \(0\)\
\-\ pe\\:\\ 0\\.017061265251315218\ \(0\)\
\-\ lobes\\:\\ 0\\.01673627740763094\ \(0\)\
\-\ may\\:\\ 0\\.016660696612427767\ \(0\)\
\-\ needed\\:\\ 0\\.01654119210293216\ \(0\)\
\-\ suggest\\:\\ 0\\.016174971961745197\ \(0\)\
\-\ linear\\:\\ 0\\.016100273658116834\ \(0\)\
\-\ cxr\\:\\ 0\\.016026810093889232\ \(0\)\
\-\ features\\:\\ 0\\.016026810093889232\ \(0\)\
\-\ general\\:\\ 0\\.016002589628255612\ \(0\)\
\-\ nodular\\:\\ 0\\.015930710253830718\ \(0\)\
\-\ pneumonia\\:\\ 0\\.015699176423237822\ \(0\)\
\-\ specific\\:\\ 0\\.015699176423237822\ \(0\)\
\-\ prominent\\:\\ 0\\.015587781006956859\ \(0\)\
\-\ progressive\\:\\ 0\\.015010840511303568\ \(0\)\
\-\ removal\\:\\ 0\\.01497236023244528\ \(0\)\
\-\ cough\\:\\ 0\\.014552243905813654\ \(0\)\
\-\ radiographic\\:\\ 0\\.014414952852394372\ \(0\)\
\-\ greater\\:\\ 0\\.014265406034091115\ \(0\)\
\-\ middle\\:\\ 0\\.013889595420633057\ \(0\)\
\-\ biopsy\\:\\ 0\\.01347419218505227\ \(0\)\
\-\ or\\:\\ 0\\.013353636652849435\ \(0\)\
\-\ \\(\\:\\ 0\\.012841986244335298\ \(0\)\
\-\ 10\\:\\ 0\\.012802774348208491\ \(0\)\
\-\ study\\:\\ 0\\.01249613936382204\ \(0\)\
\-\ density\\:\\ 0\\.01249613936382204\ \(0\)\
\-\ \\,\\:\\ 0\\.012031558467434995\ \(0\)\
\-\ clinical\\:\\ 0\\.011685821333626686\ \(0\)\
\-\ treated\\:\\ 0\\.011368225938150485\ \(0\)\
\-\ see\\:\\ 0\\.011334298716572391\ \(0\)\
\-\ pulmonary\\:\\ 0\\.011095779156533616\ \(0\)\
\-\ loss\\:\\ 0\\.011024285210970843\ \(0\)\
\-\ cystic\\:\\ 0\\.010953923143341149\ \(0\)\
\-\ focal\\:\\ 0\\.01084663824061512\ \(0\)\
\-\ edema\\:\\ 0\\.010741882175250182\ \(0\)\
\-\ ct\\:\\ 0\\.010624921363484826\ \(0\)\
\-\ 4\\:\\ 0\\.010582097356351312\ \(0\)\
\-\ y\\/o\\:\\ 0\\.010518351243642848\ \(0\)\
\-\ are\\:\\ 0\\.010354434422485348\ \(0\)\
\-\ therapy\\:\\ 0\\.010153959094402724\ \(0\)\
\-\ mild\\:\\ 0\\.010001126461916164\ \(0\)\
\-\ symptoms\\:\\ 0\\.009465144341769507\ \(0\)\
\-\ increased\\:\\ 0\\.009291043474665136\ \(0\)\
\-\ upper\\:\\ 0\\.009164802246083193\ \(0\)\
\-\ chest\\:\\ 0\\.009087684444700083\ \(0\)\
\-\ 1\\:\\ 0\\.00903700607982092\ \(0\)\
\-\ 3\\:\\ 0\\.008893224563140177\ \(0\)\
\-\ \\%\\:\\ 0\\.008859204592648922\ \(0\)\
\-\ most\\:\\ 0\\.008768156185458115\ \(0\)\
\-\ can\\:\\ 0\\.008614321566529198\ \(0\)\
\-\ lower\\:\\ 0\\.008541609197172723\ \(0\)\
\-\ \\'s\\:\\ 0\\.008373540526075756\ \(0\)\
\-\ case\\:\\ 0\\.008308908590521203\ \(0\)\
\-\ 2\\:\\ 0\\.00817824220671354\ \(0\)\
\-\ treatment\\:\\ 0\\.0076871864871150535\ \(0\)\
\-\ in\\:\\ 0\\.007491506313604532\ \(0\)\
\-\ male\\:\\ 0\\.00686758016838877\ \(0\)\
\-\ disease\\:\\ 0\\.006207722405403129\ \(0\)\
\-\ normal\\:\\ 0\\.00595383313155156\ \(0\)\
\-\ be\\:\\ 0\\.005856696548195241\ \(0\)\
\-\ from\\:\\ 0\\.005628603169574277\ \(0\)\
\-\ not\\:\\ 0\\.005488082985519713\ \(0\)\
\-\ at\\:\\ 0\\.005145614012585035\ \(0\)\
\-\ this\\:\\ 0\\.004271720948062814\ \(0\)\
\-\ and\\:\\ 0\\.004000200127382633\ \(0\)\
\-\ no\\:\\ 0\\.003824196225350231\ \(0\)\
\-\ with\\:\\ 0\\.00260009280199755\ \(0\)\
\-\ \\.\\:\\ 0\\.002366635739823085\ \(0\)\
\-\ of\\:\\ 0\\.0020711786808531277\ \(0\)\
\-\ the\\:\\ 0\\.001228882530698896\ \(0\)\
